Genem Biotech Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
as on 03-12-2024
- Paid Up Capital ₹ 30.00 K
as on 03-12-2024
- Company Age 4 Year, 6 Months
- Last Filing with ROC 31 Mar 2024
- Revenue 421.38%
(FY 2022)
- Profit 446.62%
(FY 2022)
- Ebitda 43650.88%
(FY 2022)
- Net Worth 163.59%
(FY 2022)
- Total Assets 463.92%
(FY 2022)
About Genem Biotech
The Company is engaged in the Life Sciences Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 30.00 K , as per Ministry of Corporate Affairs (MCA) records.
Mukesh Kumar and Sunita Kumari serve as directors at the Company.
- CIN/LLPIN
U33127BR2020PTC046306
- Company No.
046306
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
11 Jun 2020
- Date of AGM
30 Aug 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Patna
Industry
Company Details
- Location
Vaishali, Bihar, India
- Telephone
- Email Address
- Website
- Social Media
What products or services does Genem Biotech Private Limited offer?
Genem Biotech Private Limited offers a wide range of products and services, including Autoclaves, Sterilizers & Incubators, Lab Incubator, Laboratory & Lab Equipment, Laboratory Chamber, Cutting Machines & Equipment, Cutting Machine, Metal & Metal Made Products, Nano Powder, Plastic & Glass Labware, Laboratory Glassware.
Who are the key members and board of directors at Genem Biotech?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Mukesh Kumar  | Director | 11-Jun-2020 | Current |
| Sunita Kumari | Director | 11-Jun-2020 | Current |
Financial Performance of Genem Biotech.
Genem Biotech Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 421.38% increase. The company also saw a substantial improvement in profitability, with a 446.62% increase in profit. The company's net worth Soared by an impressive increase of 163.59%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Genem Biotech?
Unlock access to Genem Biotech's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Genem Biotech?
Genem Biotech has a workforce of 0 employees as of Mar 31, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Genem Biotech, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Genem Biotech's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
